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Abstract
Background: There are currently no guidelines for screening for thyroid peroxidase antibodies
(TPOAb) during pregnancy. Currently, there is some debate as to whether pregnant women
should be screened for TPOAb, universally, or using a risk-based approach. In addition, there is
conflicting evidence suggesting the implications of positive TPOAb testing during pregnancy
and their effect on not only the pregnancy, but also the postpartum period and the fetus.
Purpose: To determine whether TPOAb should be screened for during the first trimester of
pregnancy; and if so, to determine if a risk-based approach or universal screening method is
more appropriate.
Results: Twenty-four studies were reviewed examining antepartum complications of positive
TPOAb, postpartum complications of positive TPOAb, negative impact of TPOAb positivity on
the fetus, cost effectiveness of screening for TPOAb during pregnancy, and risk factors identified
for those more likely to have positive TPOAb levels.
Conclusion: There are enough risks associated with having positive TPOAb during pregnancy
that they should be universally screened for during the first trimester of pregnancy. If all
pregnant women are not universally screened for, then a risk-based approach should be
implemented.
Implications for Research and Practice: Certified nurse-midwives should universally screen
for TPOAb during pregnancy. They should also be aware of the costs of screening for TPOAb
during pregnancy in their facility as well as which insurance covers the cost of these tests. They
should also be aware of what to expect should complications arise in a pregnancy, postpartum,
and fetal complications of a woman with positive TPOAb.
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Chapter One: Introduction
Studies have shown that thyroid dysfunction in pregnancy can lead to an increased risk
for unfavorable pregnancy and newborn outcomes (Abbassi-Ghanavati, Casey, Spong, McIntire,
Halvorson, & Cunningham, 2010). Abbassi-Ghanavati et al. (2010) explain that thyroid disease
is more common in women, and the presence of thyroid antibodies (TPOAb) is an indicator for
future thyroid problems. Pregnant women with positive TPOAb are at an increased risk for
placental abruption, pregnancy loss, hypertension in pregnancy, preterm rupture of membranes,
preterm delivery, postpartum thyroiditis, and postpartum depression, according to AbbassiGhanavati et al. (2010).
Statement of Purpose
The purpose of this paper is to examine studies about thyroid disease and learn the way
that it impacts pregnancy and the newborn, as well as the postpartum experience of health. The
specific focus of this paper will be on the screening for presence of TPOAb in pregnancy and
how the presence of TPOAb impacts women and their offspring, specifically focusing on
whether screening should be performed at all, should be performed with targeted screening, or
should be performed universally in pregnancy. In connecting this topic to a theoretical
framework, the paper will examine Margaret Newman’s theory of health as expanding
consciousness to address how the importance of screening for TPOAb during pregnancy will
help women to evolve in their health journey as well as build relationships with their health care
providers.
Evidence Demonstrating Need
Several researchers have found correlations between subclinical hypothyroid disease and
increased incidence of risk to mother and baby during and after pregnancy (Bryant, Nelson,
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McIntire, Casey, & Cunningham, 2015). There is disagreement between several different
organizations including the Endocrine Society and the American Congress of Obstetrics and
Gynecology (ACOG) about whether or not to routinely screen for thyroid disease during
pregnancy, and whether screening should be targeted or universal.
ACOG released a practice bulletin in 2015 regarding thyroid disease in pregnancy and
their conclusion was that they do not recommend the routine screening for thyroid disease in
pregnancy (ACOG Practice Bulletin, 2015). Kilpatrick (2015) explained that the reason why
ACOG does not recommend routine screening for thyroid disease in pregnancy is because the
perceived neurological implications in the neonate of subclinical thyroid disease of the mother is
just an association and not a causation. She also explained that there are not strong studies that
show correlation between subclinical thyroid disease and adverse pregnancy outcomes. Finally, a
study was published that showed no cognitive impairment in three-year-olds of mothers with
thyroid disease who received treatment versus those that did not receive treatment (Kilpatrick,
2015).
The ACOG position statement does not solely address screening for TPOAb during
pregnancy, which is the topic specific to this paper. Much of the research regarding TPOAb
indicates that positive antibodies do show increased risks both during pregnancy and postpartum
as well as increased risks to the neonate. It is difficult to completely apply the ACOG’s position
statement to this paper, because they only briefly mention thyroid autoantibodies (ACOG
Practice Bulletin, 2015). Additionally, the ACOG position statement only references three
studies, whereas the literature review matrix for this capstone includes over twenty studies. The
ACOG position statement recommends not to universally screen women for thyroid disease,
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however they also say that more evidence is needed in regards to this topic (ACOG Practice
Bulletin, 2015).
Conversely, the Endocrine Society’s guidelines to thyroid disease in pregnancy are to
check for TPOAb in all women who are high risk for thyroid dysfunction (DeGroot et al., 2012).
The Endocrine Society explained that there is not strong enough evidence at this time to either
recommend or not recommend universal screening for TPOAb in all women in pregnancy. They
do highlight the increased risks of TPOAb positive status including miscarriage, preterm labor,
increased hypothyroidism, and postpartum thyroiditis. The Endocrine Society’s guidelines
incorporate a more thorough literature review than the ACOG’s analysis of risks during
pregnancy for women experiencing thyroid dysfunction (DeGroot et al., 2012).
Significance to Nurse-Midwifery
Approximately 10% of women test positive for TPOAb during the first trimester of
pregnancy, and the risk of developing postpartum thyroiditis after testing positive for TPOAb
ranges from 30 to just over 80% within one year postpartum (Bhattacharyya, R., Mukherjee, K.,
Das, A., Biwas, M.R., Basunia, S.R., & Mukherjee, A., 2015). Nahar, Naher, Habib, and Mollah
(2013) also explain that positive TPOAb increase the risk for postpartum depression and future
hypothyroidism by 30% each. Based on these findings, it would be worth further exploring if
universal or risk based screening of TPOAb would be a beneficial way to identify these women
sooner in order to identify and treat thyroid disease in a timely manner.
Theoretical Framework
Margaret Newman’s theory of nursing postulates that every human is on a journey to
expanding their consciousness through learning about their own health (Newman, 2011).
Newman (2011) stresses that health is not the absence of disease, rather it is putting forth the
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effort to learn more about oneself and connecting with others throughout their health journey.
This theory applies to the research question of whether one should be screening for TPOAb in
the first trimester of pregnancy, because gaining knowledge of a disease or pathology is a way of
expanding consciousness.
Newman explains that as one becomes more aware of their pathologies, they are enabled
to connect with the world around them and thus are able to develop further as human beings
(Smith, 2011). In the event that universal screening for TPOAb during the first trimester of
pregnancy was implemented, those with positive autoantibodies would become more aware of
what is happening in their bodies. Having the knowledge of the presence of TPOAb would make
it possible for women to understand that they are at an increased risk for complications like
miscarriage, postpartum depression, and postpartum thyroiditis. This way, women would be
better able to mentally prepare for these illnesses. Additionally, they would be able to work with
their health care practitioners to have a plan for managing these conditions early to prevent
complications.
One of Newman’s intentions for health as expanding consciousness in practice is that it
develops a partnership between the provider and patient in the journey to health (Jones, 2006).
This applied to universal screening of TPOAb would have a similar effect. The combined
knowledge between patient and nurse-midwife of positive TPOAb could lead to a collaborative
partnership in improving health and disease prevention in the future. Throughout this
partnership, a deeper level of caring would develop between nurse-midwife and patient which is
another one of the goals of Newman’s health as expanding consciousness. Jones (2006) explains
that within Newman’s theory, when partnership is developed, patient and nurse are able to
uncover other health implications, which leads to a healthier state of being.
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Newman emphasized that nursing, including advanced practice nursing, has to be in the
moment, and care providers have to be fully engaged with their patients in order to reap the
benefits of health as expanding consciousness (Jones, 2006). Taking this, universal screening for
thyroid autoantibodies would be a way to engage fully with a patient initially through lab values,
and then emotionally and educationally through explaining the implications of the lab values and
what that means going forward.
Margaret Newman’s nursing theory of health as expanding consciousness is one that can
be applied to all aspects of health care. As it applies to testing for TPOAb universally in the first
trimester of pregnancy, it allows for both the provider and patient to become closer, it allows for
a collaborative relationship between patient and nurse-midwife, and finally it allows for patient
insight, which can open up further information leading towards patients’ overall health and
wellbeing. Implementation of health as expanding consciousness into research regarding TPOAb
can help to lead to better planning for the future of patients who have positive thyroid
autoantibodies.
Summary
Screening for the presence of TPOAb in pregnant women is not currently done routinely,
and there has been some disagreement about whether or not screening for antibodies should be
performed for everyone or for a targeted population of individuals. Thyroid disease in pregnancy
has been shown to have adverse effects on pregnancy, the health of the woman, and the
neurophysical development of the newborn. TPOAb have been closely correlated with thyroid
disease (Nahar et al., 2013). Nurse-midwives are not only responsible for caring for women
during pregnancy, but also throughout the lifespan. Testing positive for TPOAb during
pregnancy changes the outlook of health in a woman’s lifespan, implicating the importance for

12
the nurse-midwife to provide comprehensive pregnancy care that potentially includes screening
for thyroid diseases, which does not exclude screening for TPOAb.
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Chapter II: Methods
This chapter is an overview of the processes used to critically appraise literature
regarding the screening of thyroid peroxidase antibodies (TPOAb) in pregnant women. This
chapter will discuss the search strategies used to ascertain information about research on this
topic. It will also examine the criteria for including and excluding research in the literature
review matrix. Lastly, the number and type of studies included in the literature review matrix is
reviewed in this chapter.
Search Strategies
The goal of this literature appraisal is to determine whether or not universally testing for
TPOAb in pregnant women is beneficial for their health both during pregnancy and in the future,
or whether a targeted approach to screening for TPOAb during pregnancy should be taken. Initial
searches were conducted regarding different types of thyroid dysfunction screenings and lab
values that were evaluated in pregnant women, but it became evident that there was some
discrepancy in the screening for TPOAb and how it affects women during pregnancy and
postpartum.
Initial searches were performed in the Cumulative Index to Nursing and Allied Health
Literature (CINAHL) including the search terms “TPO antibodies” and “pregnancy”. This search
yielded 207 results from the years 2001 to 2016, of which many had to be disregarded due to not
meeting criteria for the research question. Further searches were performed on the Google
Scholar search engine including the search terms “screening” “thyroid antibodies” and
“pregnancy”. This yielded 647 results from 2007 to 2016, of which many were disregarded due
to relevance or not being an original research. Further searching was completed in the search
engine Science Direct yielding 184 results from 2007 to 2017, of which many did not pertain to
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the research question, and others were already included in the Matrix. The search engine
PubMed was utilized with the terms “TPOAb”, “screening”, and “pregnancy, which yielded
fifty-two results from 1998 to 2017. These articles were already included in the literature review
matrix or irrelevant to the practice question. Finally, the search engine Scopus was utilized
spanning the years 2001 to 2016, with the search terms “TPOAb”, “screening”, and “pregnancy”,
which yielded thirty-seven results. Studies of relevance were included in the matrix and many
were not included due to not pertaining to the practice question. Many of the studies in the
literature review matrix were found in the different search engines. In addition to these search
terms, reference sections in articles were evaluated for further research studies to be included in
this critical appraisal.
Criteria for Including and Excluding Research Studies
Inclusion criteria for the literature review matrix included studies that addressed
screening ranges and parameters for TPOAb during pregnancy. Also included in the matrix were
studies that addressed risks of positive TPOAb during pregnancy, postpartum, and risks to the
fetus. Finally, studies were included that addressed risk factors for thyroid dysfunction and
TPOAb positivity as well as cost effectiveness of screening for TPOAb.
Research studies that were excluded from this critical appraisal included those that did
not involve screening for TPOAb during pregnancy. Several studies addressed screening for
thyroid stimulating hormone during pregnancy but not TPOAb, making them irrelevant to the
practice question and therefore subject to exclusion from the literature appraisal. Other studies
excluded from the literature appraisal included those that were deemed to be not of good quality
according to the Johns Hopkins Nursing Evidence-Based Practice: Model and Guidelines
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(Deerholt & Dang, 2012). Studies that were not included into the literature review matrix were
not research studies, or were research studies that did not address TPOAb in pregnancy.
Criteria for Evaluating Research Studies
Evaluation criteria employed by the Johns Hopkins methods includes the level of
evidence as well as the quality of that evidence (Deerholt & Dang, 2012). The highest level of
quality is considered level I, and this includes randomized control trials and experimental
studies. Level II includes quasi-experimental studies and studies that are a synthesis of other
studies. Level III evidence includes non-experimental studies and qualitative studies. Quality is
determined by whether the information in the study is generalizable, whether the sample size was
sufficient, and whether they contain consistent recommendations. Good quality studies include
reasonably consistent results and recommendations, as well as a fairly sufficient sample sizes.
Studies of low quality do not meet the above listed criteria and were not included in this
appraisal.
Number and Types of Studies Involved in Literature Review
The total number of studies included in the literature review matrix is twenty-four. Of
these, eight are quasi-experimental studies, which are level II and considered to be of good
quality. Eleven of the studies in the literature review matrix are observational studies including
two retrospective studies, six prospective observational studies and three longitudinal studies.
These range from level II to level III and range in quality from high quality to fair quality. The
literature review matrix contains three studies that are prospective cohort studies that are all
considered level II and good quality. One study in the literature review matrix is a secondary
analysis of quantitative data, which is level III and of good quality. Finally, the literature review
matrix includes one randomized control trial which is level I and of high quality.
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The matrix is broken down into categories including citation, purpose of the study,
sample, design type, measurement, results and conclusions, recommendations, and level and
quality of each study. Studies that were not included into the literature review matrix were not
original research studies, or were research studies that did not address TPOAb in pregnancy.
Summary
Screening for TPOAb during pregnancy is not currently routinely done. The literature
review matrix compiled several types of studies addressing this screening and organizes the
information provided in each study. The research was analyzed for level of research as well as
the quality of the research. Inclusion and exclusion criteria for the literature review matrix were
discussed as well as the criteria for evaluation of the studies.
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Chapter III: Literature Review and Analysis
This chapter serves to provide an overview of the literature from the literature review
matrix and an analysis of the findings of the studies included in the matrix. It will provide a
discussion of the major areas in which positive thyroid peroxidase antibodies (TPOAb) affect
pregnant and postpartum women and their offspring. Additionally, it will synthesize the data
collected in the literature review matrix and synthesize the significant findings.
Synthesis of Literature Review Matrix
The literature review matrix’s purpose is to organize the literature compiled and highlight
themes among the research. There are twenty-four studies in the matrix and they all are
organized using the following headings: citation, purpose, sample, design, measurement,
results/conclusions, recommendations, and level/quality. The studies in the matrix are organized
alphabetically.
Each study was appraised using Johns Hopkins research appraisal method and those that
were not of a high level of research or those that were of poor quality were excluded from the
matrix (Deerholt & Dang, 2012). Each study was appraised and then compared to the other
studies in the matrix to synthesize information.
Synthesis of Significant Findings
The literature review matrix supports screening women for the presence of TPOAb
during pregnancy, but differs in recommendations of whether to screen women universally or to
perform targeted screening based on risk factors. The major themes that arose from researchers’
findings included in the matrix are as follows: risks during pregnancy, risks during postpartum,
cost analysis of screening for TPOAb, a comparison of screening parameters, risks to the
offspring, and identification of salient risk factors should a targeted screening approach be taken.
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Risks During Pregnancy
There were eight studies that addressed the risks of having positive TPOAb during
pregnancy. This is an important factor to keep in mind when caring for pregnant women because
it indicates that women need more thorough antenatal care if they have a TPOAb positive status.
In a robust study with a sample size of 17,298 pregnant women, Abbasi-Ghanavati et al.
(2010) found that 1% of the population of TPOAb positive women experienced placental
abruption during their pregnancy 0.3% of the TPOAb negative population. Nor et al. (2010)
found in their small research study that in TPOAb positive women, 3.8% experienced placental
abruption. Bryant, Nelson, McIntire, Casey, and Cunningham (2015) found that women in the
over N= 23,000 women studied, those with unconfirmed hypothyroidism were more likely to
have hypertension during pregnancy, which may explain the increased risk of placental abruption
in the TPOAb positive population. Nor et al.’s research agrees with Bryant et al. and found that
7.7% of TPOAb positive women had hypertension in pregnancy and 15.4% of TPOAb positive
women developed preeclampsia.
Ahmed, Eid, Orabi, and Ibrahim (2014) found that women with positive TPOAb were
more likely to be high risk for having hypothyroidism during pregnancy in their relatively small
but good quality study where p < 0.05. They found that it did not matter if they separated women
into high and low risk groups; there was no change in whether elevated TPOAb would be linked
to hypothyroidism. Pradhan, Anand, Singh, and Mehrotra (2013), also found an increased risk of
hypothyroidism in TPOAb positive status in their study that included N= 2,479 pregnant women.
Of the women studied, 7.91% were found to have hypothyroidism, and of those, 40% tested
positive for TPOAb.

19
Another risk of testing positive for TPOAb during pregnancy is the increased risk of
spontaneous abortion. Two studies addressed this concern. Pradhan et al. (2013) found that of
women who tested positive for TPOAb, 17.86% of them experienced a spontaneous abortion in
the first trimester versus 6.49% of the population that tested negative for TPOAb. Pradhan et al.
(2013) found that of the TPOAb positive population, 10.71% experienced second trimester
spontaneous abortion versus 1.3% of the TPOAb negative population in the second trimester.
Bhattacharyya et al. (2015) also addressed the issue of spontaneous abortion and found that in
their study of N= 400 pregnant women, 10.8% of the TPOAb positive population experienced
SAB versus 4.8% of the TPOAb negative population.
Preterm delivery was identified by researchers to be more prevalent amongst the TPOAb
positive population in two studies listed in the literature review matrix. Meena, Chopra, Jain, and
Aggarwal (2016) found in their research population of N= 1,000 pregnant women that of the
TPOAb positive subjects in their study, 12.5% of women experienced preterm delivery whereas
of the women that did not test positive for TPOAb, only 2.5% had preterm delivery. Nor et al.
(2010) also addressed the topic of preterm delivery and found that 11.5% of TPOAb positive
women experienced this phenomenon, again their study was smaller in size.
One study addressed how TPOAb positivity and mood are related during pregnancy.
Groer and Vaughan (2013) found that women who were TPOAb positive were more likely to
score higher on a profile of mood states (POMS) questionnaire, as well as on scales for
depression and mood disorders. Their study included N= 631 pregnant women and was
considered to be of good quality.
Despite all these different findings, Bryant et al. (2015) concluded that overall pregnancy
outcomes were similar in women who have positive TPOAb to women who tested negative for
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TPOAb during the first trimester. However, the eight studies addressed in this section indicated
that, in fact, TPOAb positivity does have an effect on pregnancy outcomes, as it has a correlation
with increased risk of spontaneous abortion, hypertension during pregnancy, placental abruption,
preterm delivery, preeclampsia, hypothyroidism during pregnancy, and mood disorders in
pregnancy.
Risks Postpartum
Seven studies included in the literature review matrix addressed the risks that mothers
face postpartum should they test positive for TPOAb during their pregnancy. These risks include
postpartum thyroiditis, postpartum thyroid dysfunction in general, and postpartum depression.
These are important topics to discuss, because all of them can affect how well a woman is able to
take care of both herself and her infant.
Postpartum thyroiditis was addressed by five of the studies in the matrix. Bhattacharyya
et al. (2015) found in the women that they studied, 81.25% of the women who tested positive for
TPOAb experienced postpartum thyroiditis versus 4.7% of the general population. Ekinci et al.
(2015) found in their smaller scale study of N=140 subjects, that pregnant women who had
positive TPOAb were much more likely to experience postpartum thyroid dysfunction including
postpartum thyroiditis, as well as Hashimoto’s thyroiditis. Groer and Vaughan (2013) found that
64% of women with positive TPOAb developed postpartum thyroid dysfunction within six
months of delivery. Mamede da Costa, Siero Netto, Coeli, Buescu, and Vaisman (2007) found
that positive TPOAb status was as much as two thirds predictive for identifying women likely to
develop postpartum thyroid dysfunction in their small study of 98 pregnant women. They
identified 60% of TPOAb positive women to have postpartum thyroid dysfunction versus 4.55%
of the TPOAb negative population. They also found that on average, thyroid stimulating
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hormone (TSH) levels were more likely to be elevated at one year postpartum in women who
tested positive for TPOAb in pregnancy. Meena et al. (2016) discovered through their research
that 40% of women who tested positive for TPOAb developed hypothyroidism postpartum. Nor
et al. (2010) found that by as few as eight weeks postpartum, 19.2% of TPOAb positive women
developed postpartum thyroid dysfunction. Finally, Springer, Potlukova, Limanova, and Zima
(2012) found in their sizable study of N= 7,530 pregnant women that 40% of TPOAb positive
women experienced some sort of thyroid dysfunction within one year postpartum (p>0.20).
Groer and Vaughan (2013) determined that TPOAb positive women were more likely to
have postpartum depression following a pregnancy where they tested positive for TPOAb
(Chronbach’s alpha 0.839). They expressly stressed that these women have no other reasons for
experiencing postpartum depression such as stressors or other demographic factors at the time.
The studies compiled in the literature review matrix that address postpartum risks related
to testing positive for TPOAb indicated that there is an increased risk for thyroid dysfunction
within one year postpartum. According to the matrix, women with positive TPOAb are also at an
increased risk for postpartum depression if they have tested positive for TPOAb, however most
researchers did not address this subject.
Cost Analysis
It is important to address cost analysis when deciding whether and how to screen for
TPOAb. Additionally, when addressing cost effectiveness, it is important to identify locations
where screening is cost effective versus where it might be less cost effective. Six of the studies in
the literature review matrix addressed the topic of cost effectiveness of universal screening for
TPOAb in pregnancy.
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There are varying opinions about whether or not it is cost effective to universally screen
for TPOAb during pregnancy. Abbassi-Ghanavati et al. (2010) concluded in their study that it is
not cost effective to universally screen for TPOAb in pregnancy, however they believe that it
might be plausible to screen for TPOAb in the future if there were further studies performed to
prove its cost effectiveness. Conversly, Dosiou, Sanders, Araki, and Crapo (2008) point out that
in the United States it only costs an average of $102 to screen for thyroid stimulating hormone
(TSH) and $212 to screen for TPOAb. They believe that their high quality study enables them to
conclude that these low costs implicate that universally screening for TPOAb, as well as TSH
during pregnancy, is justified (Dosiou et al., 2008).
Nazarpour et al. (2016) have a stance neutral to the other two that have been discussed.
They state that universal screening is a cost effective procedure, however there have not been
enough studies performed at this time to fully endorse universal screening. Of note, Nazarpour et
al. performed their large study in Iran where nutritional deficiencies differ from the United
States, namely the amount of iodine consumed, which needs to be considered when addressing
this topic. Nor et al. (2010) seemingly agree with Nazarpour et al. and say that in well developed
countries, universal screening is more affordable so they recommend universally screening all
women, however in developing countries this might not be the case. Yang et al. (2014)
concluded from their study of N= 3,882 pregnant women, that since the price of testing for
thyroid dysfunction including TPOAb is relatively low, universal screening for thyroid
dysfunction during pregnancy is a cost effective option, and better than screening only targeted
risk factors for thyroid dysfunction. Finally, Dhaifalah, Salet, Kangova and Cuckle (2017)
believe that adding screening for thyroid disease on to other first trimester screening tests is
probably beneficial, however further research is needed until it can be recommended overall.
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Their recommendation is strong, as their sample size included N= 10,052 pregnant women (p>
0.0001).
Comparison of Screening Parameters
Ten of the studies addressed the accuracy of screening for TPOAb and thyroid
dysfunction in general during pregnancy. Some researchers pointed out trends in other thyroid
related markers whereas others focused on setting parameters for normal lab values for thyroid
function during pregnancy. Some researchers addressed the differences in thyroid serum levels
depending upon the ethnic background of the individuals being screened. Finally, some
researchers focused on when is the best and most accurate time to screen for thyroid disease
during pregnancy.
Four groups of researchers are in agreement that average TSH levels are higher in
pregnant women who test positive for TPOAb. Nahar et al. (2013) found in their research study
of 200 women in Bangladesh, that if TPOAb values were greater than 12IU/ml, then pregnant
women’s TSH was more likely to be higher (p<0.05 and a confidence interval of 95%). Quinn,
Reyes-Mendez, Nicholson, Compean and Tavera (2014) also found that TSH levels were more
likely to be higher in TPOAb positive pregnant women when studying 660 pregnant women
versus 104 non-pregnant women in Mexico. Springer, Potlukova, Mimanova, and Zima (2012)
found that in pregnant women with positive TPOAb, free thyroxine (fT4) levels were more likely
to be lower, however no other researchers found that to be the case in their studies. Sarkhail,
Mehran, Tahamasbinejad, Tohidi and Azizi (2016) found that 23% of women with positive
TPOAb had either hypothyroidism or subclinical hypothyroidism in at least one trimester during
pregnancy in their good-sized study of N= 466 Iranian women.
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Screening parameters and the best time to screen pregnant women for TPOAb were
addressed by two of the studies. Ekinci et al. (2015) found that the accuracy of screening for
TPOAb in pregnancy was much higher in the first trimester and the amount of positive TPOAb
tests in the second trimester decreased by 96% in the second trimester and 97% in the third
trimester of pregnancy. Sarkhail et al. (2016) found in their study that in pregnant women with
thyroid dysfunction, 45.5% tested positive for TPOAb in the first trimester but that number
dropped to 41.2% of women in the second trimester and 25% of women in the third trimester.
Five of the groups of researchers compiled in the literature review matrix addressed
parameters for TPOAb and thyroid function during pregnancy both due to the fact of women
being pregnant and in an altered body state and looking into differences in racial background and
how that affects thyroid serum levels. Hollowell et al. (2001) set out to determine reference
ranges in general for thyroid serum markers in their study of N= 631 women during pregnancy
and postpartum, and pointed out that generally White and Mexican Americans have higher levels
of TSH than do Black Americans. Hollowell et al. also pointed out that it is important to be
aware of the possible iodine deficiency in people of certain cultural backgrounds or people from
certain geographical locations. Quinn et al. (2014) stressed that narrower reference ranges should
be used in pregnant women of Mexican descent as well as emphasizing that pregnancy for all
women should have specific reference ranges for thyroid function testing. Nahar et al. (2013) set
the reference range for TPOAb to be levels greater than 12IU/ml whereas Springer, Potlukova,
Limanova and Zima set the parameters for TPOAb positivity at 143 IU/ml. Finally, Springer,
Bartos, and Zima (2014) emphasized after their study of N= 229 pregnant women, that
parameters for TPOAb should be set lower in pregnancy than they would be in a non-pregnant
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state (p<0.05). All of these parameters are important for practitioners to keep in mind when
screening pregnant women for thyroid dysfunction.
Risks to the Offspring
Positive TPOAb status in women has been shown in some studies to affect offspring.
Four of the studies in the literature review matrix addressed the effects that positive TPOAb
during pregnancy has on the pregnant mother’s offspring. They not only focused on issues that
can arise at birth, but also long-term effects of positive TPOAb in the mother.
Nor et al. (2010) found that in pregnant women with positive TPOAb, 15.4% had babies
with IUGR. Meena et al. (2016), however, discovered no difference in incidence of IUGR in
babies of mothers with positive TPOAb. Pradhan et al. indicated that 17.86% of infants had
malformations if their mother was positive for TPOAb versus only 6.4% of babies born with
malformations in TPOAb negative mothers. Sarkhail et al. (2016) stated that TPOAb positivity
in the first trimester is the most likely time for the fetus to be affected, since that is when much
of development takes place. Wasserman et al. (2007) performed a study with a sample size of N=
1,859 children whose mothers who tested positive for TPOAb during pregnancy and found that
7.5% of these children had sensorineural hearing loss versus only 1.3% of the total population
(p>0.20).
Though there has been little research done on the effects of positive TPOAb in pregnancy
on the offspring, the research that has been completed does indicate that the children of affected
mothers are more likely to suffer negative effects during the pregnancy, immediately at birth, as
well as later in life. When addressing effects of TPOAb positivity on the offspring, it would be
prudent to consider the implications that preterm delivery and placental abruption have upon the
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affected newborns. See the section above on risks during pregnancy for the corresponding risks
in the literature.
Risk Factors
If universal screening for TPOAb during pregnancy is not the most cost effective option
in a particular setting, then targeted screening is another option to explore. Six of the studies in
the literature review matrix address risk factors for thyroid dysfunction during pregnancy. This
section will discuss the risk factors identified.
Yang et al. (2014) found that TPOAb positivity was only slightly higher in the population
that they deemed high-risk versus the population that was deemed low-risk. The risks that Yang
et al. (2014) identified were based on patient history, physical exam at presenting appointment,
and any other implications of thyroid dysfunction such as symptomatic identifiers including
fatigue, weight gain, and hair loss. Springer, Potlukova, Limanova, and Zima (2012) identified
four risk factors for women more likely to have positive TPOAb and overall thyroid dysfunction
including age greater than thirty, family history of thyroid dysfunction, personal history of
thyroid dysfunction, and the presence of a goiter upon examination. They found that 11.5% of
women with these markers were positive for TPOAb. Pradhan et al. (2013) found that 40% of
women with hypothyroidism had positive TPOAb. Nazarpour et al. (2016) identified risk factors
including age greater than thirty, family history of thyroid disease, and history of spontaneous
abortion. When Nazarpour et al. (2016) separated their subjects into high and low risk categories,
39.6% of the high risk group were found to have thyroid disorders versus 27.4% of the low risk
group. Mamede da Costa et al. (2007) identified increased risk factors for developing thyroid
dysfunction were family history of thyroid disease and the presence of a goiter upon physical
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examination. Finally, Bryant et al. (2015) pointed out in their article that age greater than thirtyfive increases risk for hypothyroidism.
Compiling all of the risk factors addressed by the studies, the main risk factors identified
for thyroid dysfunction during pregnancy and postpartum include being greater than thirty years
of age, family history of thyroid disease, personal history of thyroid dysfunction, and presence of
a goiter upon examination.
Summary
There is not a consensus for how to approach screening for TPOAb during pregnancy
among medical societies, however themes have arisen in the literature review matrix, which may
help providers to decide whether they should screen for TPOAb at all, use a targeted screening
for pregnant individuals, or universally screen all pregnant women. These themes include
understanding the risks of thyroid disease during and after pregnancy for both the woman and
her offspring, the cost analysis of screening for TPOAb, parameters for testing for thyroid
dysfunction in pregnancy, and the risk factors that should be focused on if targeted screening is
chosen as the preferred method. Despite everything compiled in the literature review matrix,
overarching opinion is that more research is needed in regards to whether TPOAb should be
screened for, and if so, should a universal or targeted screening approach be utilized.
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Chapter IV: Discussion, Implications, and Conclusion
This chapter will contain a critical appraisal of the literature that has been discussed in
previous chapters. It will also include a synthesis of literature, the current trends in practice along
with a discussion of the gaps in research, the implications for future research and practice, and
application and integration of the theoretical framework discussed in chapter one. This critical
appraisal of literature will help to elucidate the recommendations for thyroid antibodies (TPOAb)
screening in pregnancy, whether that means to not screen for them at all, to perform targeted
screening for at risk women, or to universally screen for TPOAb in the first trimester.
Literature Synthesis
The research question that was the basis for all of the research collection was whether or
not nurse-midwives and all obstetrical providers should be screening women for TPOAb during
the first trimester of pregnancy in order to improve outcomes during pregnancy and postpartum.
Current trends and gaps in research
Cost effectiveness. Current trends in screening for TPOAb are varied. Some practitioners
do not screen for them at all. Some practitioners believe that they should routinely screen
everyone during pregnancy because of the cost effectiveness of the testing in the United States
(Dosiou, Sanders, Araki, & Crapo, 2008). The aforementioned researchers indicated in their
study that the testing is inexpensive and therefore, should be utilized. Other researchers agree
with this and suggest universally screening all pregnant women for TPOAb because it is
inexpensive (Yang et al., 2014). Conversely Abbassi-Ghanavati et al. (2010) state that the cost is
not worth universal screening for TPOAb in pregnancy, however they believed that further
research was needed in regards to this topic. While one group of researchers reported that cost is
less likely to be an issue in developed countries, however in developing countries universal
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screening might not be a reasonable guideline to follow (Nor et al., 2010). There is still more
research needed in regards to whether or not it is cost effective to screen for TPOAb universally
during the first trimester of pregnancy, however in developed countries it appears that universal
screening would be a cost effective choice.
Timing and accuracy of screening. It is generally agreed upon by all researchers that
accuracy of screening for TPOAb in pregnancy decreases after the end of the first trimester
(Ekinci et al., 2015; Sarkhail, Mehran, Tahamasbinejad, Tohidi, & Azizi, 2016). It is
recommended that to obtain the most accurate results, women should be screened for TPOAb in
the first trimester of pregnancy in order to assess for thyroid disease that might affect pregnancy.
Risks during pregnancy. Several researchers focused on the risks to pregnancy in women
who were positive for TPOAb. Risk of first trimester spontaneous abortion was found to be
higher in pregnant women with positive TPOAb by Bhattacharyya et al. (2015) and Pradhan,
Anand, Singh, and Mehrota (2013). The presence of TPOAb in women with recurrent pregnancy
loss could be the answer to the question of why someone has had multiple spontaneous
abortions. Two groups of researchers found that there was an increased risk of hypertensive
disorder during pregnancy in women with positive TPOAb including pregnancy induced
hypertension and preeclampsia (Bryant, Nelson, McIntyre, Casey, & Cunningham, 2015; Nor et
al., 2010). The risks associated with pregnancy induced hypertension, as well as preeclampsia,
can contribute to placental insufficiency as well as placental abruption, which Abbassi-Ghanavati
et al. (2010) and Nor et al. (2010) mentioned to also be correlated with presence of TPOAb in
pregnant women. It was also found that women with positive TPOAb were more at risk for
experiencing preterm labor and birth (Meena, Chopra, Jain, & Aggarwal, 2016; Nor et al., 2010).
Women with positive TPOAb were also more likely to experience hypothyroidism during
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pregnancy in addition to mood disorders during pregnancy including anxiety and depression
(Ahmed, Eid, Orabi, Ibrahim, 2014; Groer & Vaughan, 2013). Contrary to most studies, some
researchers reported that the overall outcomes of pregnancy were comparable to women negative
for TPOAb (Bryant et al., 2015). From these findings, it can be concluded that further research is
needed to discover the relationship between TPOAb and these increased risk factors during
pregnancy.
Postpartum risks. Women with positive TPOAb during pregnancy were found by several
researchers to be more likely to experience postpartum thyroid disease within one year of
pregnancy (Bhattacharyya et al, 2015; Ekinci et al., 2015; Groer & Vaughan, 2013; Mamede da
Costa, Siero Netto, Coeli, Buescu, & Vaisman, 2007; Meena et al., 2016; Nor et al., 2010;
Springer, Potlukova, Limanova, & Zima, 2012). Women with positive TPOAb are also at an
increased risk for postpartum depression (Groer & Vaughan, 2013). Further investigation is
needed regarding postpartum risks of TPOAb during pregnancy, because some of the researchers
only followed women for eight weeks postpartum whereas others followed women for twelve
months postpartum. Those that followed women for a longer amount of time had more subjects
with positive TPOAb that developed postpartum thyroid disease than those that only followed
women for eight weeks (81.2% versus 19.2% of women) (Mame da Costa et al, 2007; Springer
et al., 2012).
Potential risks to the fetus/newborn. Positive TPOAb are more likely to affect the fetus
during the first trimester, which is the most vital time for embrologic and fetal development
(Sarkhail et al., 2016). This means that fetuses of mothers with positive TPOAb are more likely
to be born with malformations versus those that were born to mothers who were negative for
TPOAb (Pradhan et al., 2013). Additionally, one group of researchers found that babies were
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more likely to be born with intrauterine growth restriction if their mothers were positive for
TPOAb (Nor et al., 2010). One study indicated that children were more likely to suffer from
sensorineural hearing loss when born to mothers positive for TPOAb (Wasserman et al., 2007).
Conversely one group of researchers found there to be no difference in fetal outcomes after a
TPOAb positive pregnancy (Meena et al., 2016). More research is needed on how positive
TPOAb results affect not only fetal development but also long term implications for babies born
to mothers positive for TPOAb.
Risk factors for targeted screening. Many researchers agreed that risk factors for women
to have positive TPOAb during pregnancy includes having personal history of thyroid disease
including the presence of a goiter on physical exam, as well as family history of thyroid disease,
and being aged thirty or greater (Bryant et al. 2015; Mamede da Costa et al., 2007; Nazarpour et
al., 2016; Pradhan et al., 2013; Springer et al., 2012). They are all in agreement with the risk
factors although some specify over the age of thirty while others do not list age as a risk factor
until the age of thirty-five has been reached.
Recommendations for Future Research
There are some areas regarding screening for TPOAb during pregnancy that need further
research. One area is a more thorough appraisal of whether or not screening for TPOAb is cost
effective, and in addition to that whether universal screening is more cost effective than just
targeted screening, or not screening for them at all. The cost effectiveness needs to be compared
against the potential damage and associated costs that thyroid disease would have on pregnancy,
postpartum, and on the fetus. Dosiou et al. (2008) reported that in the U.S. the damage of thyroid
disease is more expensive than screening each woman universally. Abbassi et al. (2010) also
performed their research in the U.S., but came to a different conclusion. This implicates that
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further research is needed regarding overall cost effectiveness of universal screening, targeted
screening, and the cost of the personal and financial hardship once thyroid disease develops.
Research also needs to be performed on cost effectiveness of screening versus personal damages
from untreated thyroid disease postpartum as well as pregnancy related issues caused by TPOAb.
Further research is also needed in regards to risks to the fetus, as there are some
disagreements in literature about whether a mother’s positive TPOAb has negative implications
for the fetus. Small sample sizes and limited research on implications to the fetus are two other
reasons why further research is needed on this topic. Especially in looking for trends between
races to try and identify more at risk groups.
Finally further research is needed in how positive TPOAb affect pregnancy outcomes so
that a plan can be set in place for prevention or early disease detection for potential negative
pregnancy outcomes such as spontaneous abortion, hypertensive disorders, and preterm labor.
Implications for Practice
Nurse-midwives are enabled to take information from the literature analyzed and apply it
to practice in several ways. First, they can research common insurance companies in their area
and their willingness to cover screening for TPOAb and other thyroid markers during pregnancy
in order to screen for thyroid issues in the most cost effective way. Nurse-midwives should also
be aware of the cost of each individual blood test through their hospital system or lab so they are
aware of the cost that screening inflicts upon their patients and insurance companies. This may
differ between systems and labs because Dosiou et al. (2008) and Yang et al. (2014) found
screening for thyroid disease to be low cost, whereas Abbassi et al. (2010) found it to be too
expensive to be utilized for every pregnant patient. Nurse-midwives should also educate their
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patients about the labs that they are planning on drawing so that they can check into the cost with
their individual insurance policies.
Nurse-midwives can also utilize the information collected in the literature synthesis and
apply it to women who have a history of pregnancy issues including pregnancy-induced
hypertension, history of preterm delivery, the birth of a baby diagnosed with intrauterine growth
restriction, history of spontaneous abortion during the first or second trimester, or history of
previous postpartum thyroiditis, and screen them for TPOAb in subsequent pregnancies. This is
in part, a targeted screening based on risk factors found in the literature (as described by Bryant
et al, Mamede da Costa et al., Nazarpour et al., Pradhan et al., and Springer et al.)
Screening for TPOAb during pregnancy is a prudent test for providers to perform for
their pregnant patients in the first trimester. Helping to elucidate why some problems during
pregnancy may occur, as well as prepare to meet problems early on during pregnancy or the
postpartum period is beneficial for patients, especially since in the United States screening for
TPOAb is a relatively low cost lab option. Anticipating a host of complications with a patient
with positive TPOAb during pregnancy and in the postpartum period provides more thorough
patient care. Additionally, knowing that the presence of TPOAb during pregnancy could lead to
fetal malformation, level II ultrasounds could be set up for patients to catch any potential issues
with the fetus. Though further research is needed on the topic, there are many positive factors to
screening for TPOAb during the first trimester of pregnancy universally for all women. If this is
not plausible, then a targeted screening approach should be undertaken.
Application and Integration of Margaret Newman’s Theory of Nursing
Margaret Newman’s theory of expanding consciousness is applicable to screening for
TPOAb during the first trimester of pregnancy because the ultimate goal of Newman’s theory is
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to learn more about individual health in order to be more aware of health problems and therefore
take care of oneself by being aware of personal health implications (Newman, 2011). Newman
continually stresses that her theory of health is not focused on the absence of disease, rather the
awareness of what is within the body and how to address potential issues.
The benefits of screening for TPOAb during the first trimester of pregnancy align with
Newman’s theory of expanding consciousness because it elucidates future problems that the
mother and fetus could encounter. Having this awareness is consciousness expanded of health for
both the patient and the nurse-midwife. With this knowledge, they can work together in order to
achieve the healthiest and safest pregnancy possible as well as be keenly aware of risks that may
develop later on in the pregnancy.
Conclusion
This literature review compiled research from twenty-four studies and utilized the Johns
Hopkins Research Evidence Appraisal Tool in order to analyze the quality and level of research.
This tool and the matrix indicate that the main topics that come to light when looking into
research regarding screening for TPOAb during pregnancy include risks during pregnancy,
postpartum risks, risks to the fetus, cost effectiveness of screening for TPOAb, and risk factors
for targeted screening for TPOAb. The most common risks during pregnancies with positive
TPOAb are hypertensive disorders, spontaneous abortion during first and second trimester,
thyroid disorder, placental abruption, preterm labor, and mood disorders in pregnancy. Risks
postpartum include postpartum thyroid disease, which is the most common risk, as well as
postpartum depression. Risks to the fetus include fetal malformation, intrauterine growth
restriction, and sensorineural hearing loss. Cost-effectiveness includes the financial benefits of
screening universally as well as a discussion of where, globally, it is most cost effective to screen
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for TPOAb in pregnancy. Finally, risk factors highlighted in the event that targeted screening for
TPOAb is chosen include history personal or family of thyroid disease, presence of a goiter, and
age over thirty. Screening for TPOAb during pregnancy comply with Newman’s theory of health
as expanding consciousness because when found, both patient and provider become more aware
of that individual’s health and are able to address potential issues more proactively. Nursemidwives can provide better care for their pregnant patients if they screen universally for TPOAb
during pregnancy because they are then better able to anticipate issues that may arise for women
if they have positive TPOAb. In this way, nurse-midwives can more closely monitor women
during pregnancy for the pregnancy risks, as well as anticipate postpartum thyroid disease and
diagnose it earlier in the postpartum period.
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64 were found to
be high risk

Thyroid
function tests
including:
TSH, Free T4,
Free T3, and
anti-thyroid
peroxidase.

X2 test to
compare
qualitative
variables

No difference
was found
between low and
high risk groups
of clinical or
subclinical
hypothyroid with
TSH or fT3
Elevated TPO
and fT4 were
more prevalent in
the high risk
group
75 total patients
had
hypothyroidism
with no statistical
significance
between being
high and low risk.

Recommendations
Categorizing women
into high or low risk
groups causes missed
diagnosis of
hypothyroidism; so
pregnant women
should be universally
tested for
hypothyroidism.

Level/
Quality

Level II
Good
Quality
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Bhattacharyya,
R., Mukherjee,
K., Das, A.,
Biwas, M.R.,
Basunia, S.R.,
& Mukherjee,
A. (2015).
Anti-thyroid
peroxidase
antibody
positivity
during early
pregnancy is
associated with
pregnancy
complications
and maternal
morbidity in
later life.
Journal of
Natural
Science,
Biology and
Medicine, 6(2),
402-405. doi:
10.4103/09769668.160021

To ascertain if
assessing for
thyroid
autoantibodies
in the first
trimester of
pregnancy has
an affect on the
outcome of
pregnancy or
postpartum
thyroid disease.

400 pregnant
women (8-12
weeks
gestation)
from April
2011October
2012

Design
Prospective
cohort study
Participants
found to have
abnormal
thyroid
function at 12
weeks
postpartum
were followed
up every 8
weeks up to
12 months
postpartum.

Measurement
FT4, FT3,
TSH, and
TPOAb
measured at
first antepartum
visit and then
repeated 12
weeks
postpartum.

Results/
Conclusions

46 (11.5%) of the
mothers tested
positive for
TPOAb.
11.34% of
euthyroid mothers
tested positive for
TPOAb and
14.28% of
subclinical
hypothyroid
mothers tested
positive for
TPOAb.
Average TSH
levels were higher
in TPOAb
positive mothers.
10.87% of
TPOAb mothers
suffered from
SAB. Vs 4.8% of
TPOAb negative
mothers.
PPTD developed

Recommendations
Women who test
positive for TPOAb
in the first trimester
should be monitored
closely as they are at
a higher risk for SAB
and preterm delivery
as well as increased
risk of developing
postpartum
thyroiditis.

Level/
Quality

Level II
Good
Quality

45
in 4.7% of the
women and of
those women,
81.25% were
positive for
TPOAb.
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Design
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Bryant, S.N.,
Nelson, D.B.,
McIntire, D.D.,
Casey, B.M., &
Cunningham,
F.G. (2015). An
analysis of
populationbased prenatal
screening for
overt
hypothyroidism. American
Journal of
Obstetrics and
Gynecology,
213(4), 565.e1565.e6. doi:
10.1016/j.ajog.
2015.06.0601

To analyze
the outcomes
of
pregnancies
of individuals
diagnosed
with
hypothyroidism that
were
identified in
populationbased
screening.

Sample
taken
from
26,518
women
prenatally
at
Parkland
Hospital
from Nov.
2000April
2003.

Secondary
Analysis of
Quantitative
data.

Chart review
completed by
nurses to ascertain
demographic data
pregnancy and
birth outcomes
(including
cesarean delivery,
newborn weight,
and hypertension
after 20 weeks of
pregnancy)

Serum
thyroid
panel levels
taken at
initial
prenatal
visit.
Thresholds:
TSH >3.0
mU/L
fT4 <0.9
ng/dL

2 tailed
probability value
of <0.05 deemed
significant.

Results/
Conclusions

47 women had overt
hypothyroidism
183 women had positive
screenings for
hypothyroidism but were
unconfirmed.
25% of women with
overt hypothyroidism
were over the age of 35.
Women that screened
positive but had
unconfirmed
hypothyroidism were
found more likely to
develop pregnancyrelated hypertension.
Pregnancy outcomes
were similar in women
that screened positive
for hypothyroidism, but
were not confirmed (no
treatment) to those that
received treatment to
those who have
euthyroid.

Recommendations
This study suggests
that universally
screening for thyroid
dysfunction
prenatally is an
option for helping to
diagnose and treat
some hypothyroid
disorders. However,
since they found the
same incidence of
hypothyroid that they
were already getting
before they started
the universal
screening process
they cannot
recommend that
universal screening is
the best option.

Level/
Quality

Level III
Good
Quality
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Costeria, M.J.,
Oliveira, P.,
Ares, S.,
Roque, S.,
Morreale de
Escobar, G., &
Palha, J.A.
(2010).
Parameters of
thyroid
function
throughout
and after
pregnancy in
an iodinedeficient
population.
Thyroid,
20(9), 9951001. doi:
10.1089/thy.2
009.0356

To define the
parameters of
normal thyroid
hormone
function
during
pregnancy and
up to one year
postpartum in
a mild to
moderate
iodine
insufficient
population.

118 pregnant
women who
were
negative for
thyroid
antibodies in
Portugal
between
January 2003
to December
2005

Design
Quasiexperimental
study
Food intake
questionnaire
Serum
collected in
each trimester
of pregnancy,
intrapartum,
and
postpartum at
3 days, 3
months, and 1
year after
delivery
measuring
total T4, free
T4, total T3,
free T3, TSH,
Tg, anti—
TPO and AntiTg antibodies
using
DYNOtest

Measurement
Statistical
analyses
performed with
the SPSS 15
software and
values were
considered
reliable if
p<0.05.

Results/
Conclusions

FT4 levels during
pregnancy were
always lower than
postpartum.
TT4, TT3, and TBG
were higher during
pregnancy than after
delivery (by 25%).
FT4, FT3, and TSH
levels changed
significantly
between all
trimesters.
TT4 changed
significantly
between second and
third trimesters.

Recommendations

Level/
Quality

Since TSH is usually Level II
lower during the first Good
trimester of
Quality
pregnancy, the TSH
cutoff of 2.5 mIU/L
might be too high to
catch all of those with
subclinical
hypothyroidism.
This needs to be
studied on a larger
population.
More knowledge is
necessary about
iodine insufficiency.
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Citation

Purpose

Sample

Design

Measurement

Dhaifalah, I.,
Salek, T.,
Langova, D.,
& Cuckle, H.
(2017).
Routine first
trimester
screening for
maternal
thyroid
disease.
Journal of
Fetal
Medicine, 15. Doi:
10.1007/s405
56-017-01128

To determine
how much
screening for
thyroid
disease in the
first trimester
of pregnancy
applies a
burden to
endocrinology
as well as the
effectiveness
of combining
screening for
thyroid
disease with
other
screening tests
in the first
trimester.

10,052
Pregnant
women in
the first
trimester
from
November
2009September
2015 in the
Czech
Republic.
(2 phases,
the first
phase
ended in
March
2013).

Quasiexperimental
Study

TPOAb
considered
positive if
greated than 5.6
IU/ml. TSH
range 0.354.94mU/L, fT4
range 9.0-19.1
pmol/L.

In phase one,
TPOAb, TSH
and fT4 were
screened for.
In phase 2,
fT4 was left
out.

Symptomatic
thyroid disease
sufferers prior to
pregnancy were
excluded from
the study.
P> 0.0001, chi
square test

Results/
Conclusions

1190 women (11.8%)
were considered to be
outside of the range
and sent for
endocrinology
referral.
338 women (3.4%) of
women had positive
TPOAb.

Recommendations
It may be beneficial to
routinely screen
pregnant women for
thyroid disease in the
first trimester when
other screening tests
are performed,
however further
research is needed.

Level/
Quality

Level II
Good
Quality
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Dosiou, C.
Sanders, G.D.,
Araki, S.S., &
Crapo, L.M.
(2008).
Screening
pregnant
women for
autoimmune
thyroid
disease: a costeffective
analysis.
European
Journal of
Endocrinology,
158, 841-851.
doi:
10.1530/EJE07-0882

To
determine
when it is
cost
effective to
screen
pregnant
women for
thyroid
disease.

Women in
the US in
their first
trimester
of
pregnancy
between
the ages of
15 to 45
with no
history of
thyroid
disease.

Randomized
control trial
with the
following
groups

Markov health
transition tree
was utilized to
see trends in
overall costs
and savings.

1. No
screening
2. Screening
TSH only
3. Screening
for TPOAb
and then
further
screening for
TSH if Ab
were
positive.

Results/
Conclusions

Overall it is cost
saving to screen TSH
in early pregnancy
(overall savings of
$102 per patient).
Screening for
TPOAb overall was
also cost effective
($212 per patient).
It is cost effective to
screen for thyroid
disease because the
overall damage of
undiagnosed thyroid
disease costs more
than does the
screening.

Recommendations
Screen pregnant
women in the first
trimester for either
TSH or TPOAb to
rule out thyroid
disease.

Level/
Quality

Level I
High Quality
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Citation
Ekinci, E.I.,
Chiu, W.L., Lu,
Z.K., Sikaris,
K., Churilov,
L., Bittar, I.,
Lam, Q.,
Crinis, N., &
Houlihan, C.A.
(2015). A
longitudinal
study of thyroid
autoantibodies
in pregnancy:
the importance
of test timing.
Clinical
Endocrinology,
82(4), 604-610.
Doi:
10.1111/cen.12
571

Purpose
To ascertain the
best time during
pregnancy in
which to test for
TPOAb and
TgAb to help
detect
hypothyroidism
and PPTD

Sample

Design

140 women
in
Melbourne
Australia
less than 13
weeks
pregnant.

Longitudinal
Study
TPOAb,
TgAb, TSH
and FT4
measured at
1st, 2nd, and
3rd trimester
as well as
postpartum.

Measurement
Longitudinal
random-effect
logistic
regression
measured the
relationship
between time
and whether
TPOAb status
was positive or
negative.

Results/
Conclusions

13 (9.29%) positive
for TPOAb and 15
(10.71%) positive
for TgAb during the
first trimester
Odds of having a
positive TPOAb test
in 2nd trimester were
decreased by 96%
and in the 3rd
trimester by 97%.

Recommendations
TPOAb and TgAb
decreased between
12-25 weeks
gestation so it should
be tested for in early
pregnancy.

If negative thyroid
antibody tests are
found at the second
or third trimester, it
does not mean that
the women will not
Odds of having a
have thyroid
positive TgAb test in problems.
the 2nd and 3rd
trimesters were 99%
decreased.
13 out of 83 women
(16%) had PPTD by
20 weeks
postpartum 32%
were TPOAb
positive versus 5.1%
who were TPOAb
negative. It was
higher in women
who had TPOAb or
TgAb positivity.

Level/
Quality

Level II
Good
Quality
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Citation
Groer, M.W.,
&Vaughan, J.H.
(2013). Positive
thyroid
peroxidase
antibody titer is
associated with
dysphoric moods
during pregnancy
and postpartum.
Journal of
Obstetric,
Gynecologic, &
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Nursing: Clinical
Scholarship for
the Care of
Women,
Childbearing
Families, &
Newborns, 42(1),
E26-E32. Doi:
10.1111/j.15526909.2012.01425.
x

Purpose
To observe
women’s
moods who
tested
positive for
TPOAb
during
pregnancy
and
postpartum.

Sample

Design

631 pregnant
women then
63 who
screened
TPOAb
positive and a
convenience
sample of 72
TPOAb
negative
women.

Longitudinal,
correlational,
two-group,
observational
study.
The women
followed up
with blood
tests monthly
for six months
postpartum.

Measurement
TPOAb serum
testing
Demographic
Profile of Mood
States or POMS
questionnaire.
Perceived Stress
Scale.
Thyroid
Symptom
Checklist

Results/
Conclusions

Cronbach’s alpha
for the PSS0.839
POMS 0.91
During
pregnancy,
TPOAb positive
women scored
higher on the
POMS scale
including
depression and
other dysphoric
moods.
64% of TPOAb
positive women
developed PPTD
within 6 months
postpartum.
Postpartum
depression and
high POMS
scores were more
common among
TPOAb positive
women

Recommendations
Routine TPOAb
screening might help
to predict and prevent
postpartum
depression since
dysphoric moods are
more common among
women who test
positive for TPOAb.

Level/
Quality

Level II
Good
Quality
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Hollowell, J.G.,
Staehling, N.W.,
Flanders, D.,
Hannon, W.H.,
Gunter, E.W.,
Spencer, C.A.,
&Braverman,
L.E. (2001).
Serum TSH, T4,
and thyroid
antibodies in the
United States
population
(1988 to 1994):
National health
and nutrition
examination
survey
(NHANES III).
The Journal of
Clinical
Endocrino-logy
and Metabolism,
87(2), 489-499.
Retrieved from:
http://press.endoc
rine.org/doi/full/1
0.1210/jcem.87.2.
8182

To find a
reference
range for
TSH, fT4, and
TPO Ab for
the general
population.

17,353 people
over the age of
12 years old
who
participated in
the NHANES
III and had
thyroid studies
without
preexisting
thyroid
disorders.

Retrospective
study
fT4 using
immunoassay
reference
range
57.9nmol/L
to 169.9
nmol/L
TSH
reference
range 0.394.6 mlU/L
TPO Ab
normal range
less than <0.5
IU/mL and
TgAb normal
range, 1.0
IU/mL

Measurement
Calculation of
prevalence,
prevalence
distance, and
prevalence ratios
while using a
logistic
regression.

Results/
Conclusions

4.6% of the
population
studied had
hypothyroidism.
Mean TSH for
population was
1.4 mIU/L.
White study
participants had a
higher TSH than
Black
participants.
Mean fT4 for
population was
112.3 +/0.7nmol/L
TPO Ab were
present in 13% of
the population
and TgAb were
present in 11.3 %
of the population.

Recommendations
Keep in mind that
Whites and Mexican
Americans have
higher TSH levels
than Blacks.
TSH levels in the
Black population
needs further
research.
Early detection is
important, especially
in women who have
higher TSH levels.
The iodine nutrition
of the general
population needs to
continue to be
monitored as it may
affect thyroid
function.

Level/
Quality

Level III
High
Quality
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Mamede da
Costa, S.,
Siero Netto,
L., Coeli,
C.M., Buescu,
A., &
Vaisman, M.
(2007). Value
of combined
clinical
information
and thyroid
peroxidase
antibodies in
pregnancy for
prediction of
postpartum
thyroid
dysfunction.
American
Journal of
Reproductive
Endocrinology
, 58(4), 344349. Doi:
10.1111/j.160
00897.2007.005
08.x

To determine
if TPOAb
positivity in
early
pregnancy is
a predictor
for PPTD
within 1 year
of giving
birth.

98
Pregnant
women
from
March
2000 to
June
2003.

Concurrent
Cohort Study

95% CI of 4.116.3 for TSH and
60%, 95.5%, and
60% for positive
TPOAb.

TPOAb ,
TSH, and FT4
levels tested at
9-12 weeks
gestation, 6
months
postpartum,
and 12 months
postpartum.
Patients
answered a
symptoms and
family history
questionnaire
and underwent
examination
by a
physician.

Results/
Conclusions

10 women (10.2%)
were positive for
TPOAb.

Recommendations

Screen all pregnant
women for TPOAb
and follow up with
TSH and FT4 in all
At 12 months
trimesters in TPOAb
postpartum, TSH
positive women. This
levels were slightly is because women
higher in women
with TPOAb
who were positive positivity are at
for TPOAb.
higher risk for
pregnancy
6 out of 10 TPOAb complications and
women developed loss as well as PPTD.
PPTD (60%) vs. 4
out of 88 (4.55%).
Women were at
higher risk for
PPTD if they had
family history of
thyroid
dysfunction and if
they presented at
initial appointment
with a goiter.

Level/Quality
Level II
Good Quality
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Meena, M.,
Chopra, S.,
Jain, V., &
Aggarwal, N.
(2016). The
effect of antithyroid
peroxidase
antibodies on
pregnancy
outcomes in
euthyroid
women.
Journal of
Clinical
Diagnostic
Research,
10(9), QC04QC07. Doi:
10.7860/JCD
R/2016/1900
9.8403

To determine
the risk of the
presence of
TPOAb in a
euthyroid
woman
during
pregnancy.

1000
Pregnant
women who
presented to
an outpatient
clinic in India
from
December
2012December
2013.
Euthyroid
women with
positive
TPOAb were
separated and
then studied
throughout
the rest of the
study
(40/1000)
and studied
against 40
women in a
control group
with all
normal serum
results.

Prospective
Study.

Statistically
analyzed with
SPSS software
for standard
deviation, mean,
distribution,
range, and
Student’s t-test.

Serum
samples
taken during
the first 20
weeks of
pregnancy
and then the
women with
positive
TPOAb but
otherwise
normal
thyroid
function
were
followed
through
pregnancy.

Results/
Conclusions

16/40 (40%) of
TPOAb positive
women developed
hypothyroidism
postpartum.
5/40 (12.5%) of
TPOAb women
experienced preterm
delivery vs.
1/40(2.5%) of the
control group.

Recommendations
It may be beneficial to
screen for TPOAb
during pregnancy to
diagnose a population
as at risk for further
problems in the future.
A larger, more diverse
population should be
studied to see if the
conclusions are
similar.

Level/
Quality

Level II
Good
Quality
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Moleti, M.,
Presti, V.P.L.,
Mattina, F.,
Mancuso, A.,
De Vivo, A.,
Giorgianni, G.,
Di Bella, B.,
Trimarchi, F.,
& Vermiglio,
F. (2009).
Gestational
thyroid
function
abnormalities
in conditions
of mild iodine
deficiency:
Early
screening
versus
continuous
monitoring of
maternal
thyroid status.
European
Journal of
Endocrinology, 160(4),
611-617. doi:
10.1530/EJE08-0709

To
determine
whether it
is
beneficial
to assess
thyroid
function in
early
pregnancy
to test for
iodine
deficiency
and thyroid
underfunctioning

220
pregnant
women
living in
North
Eastern
Sicily
which is a
region
known to
have
iodine
deficiency.

Design

Measurement

Observational Circulating
study
TSH, fT4,
TPO-Ab, and
Tg-Ab using
Levels taken
kits from
in first,
Roche
second, and
Diagnostics.
third
trimesters
Inter and Intraassay
coefficients of
<5%

Results/
Conclusions

Overt and subclinical
hypothyroid affected 26
out of the 220 women
tested.
15/26 (57.7%) of
women were identified
in the first trimester. Of
the women left, 6 were
identified in the early
second trimester and 5
were identified in the
late second trimester.
82 out of 220 women
received iodine
supplementation during
pregnancy for low
levels of fT4, all of
these women’s fT4
levels normalized within
4 weeks of birth.

Recommendations
The study suggests
that women of
childbearing age
should take iodine
supplements since
iodine deficiency is
the lead cause of
thyroid dysfunction
in pregnancy.
They suggest that for
areas known to have
iodine deficiency,
targeted screening
times for thyroid
dysfunction should
be addressed using a
cost-based analysis.

Level/
Quality

Level III
Good
Quality
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Nahar, U.N.,
Naher, Z.U.,
Habib, A., &
Mollah, F.H.
(2013).
Assessment
of thyroid
peroxidase
antibody and
thyroid
stimulating
hormone in
the first
trimester.
Bangladesh
Journal of
Medical
Science,
12(2), 164170. Doi:
10.3329/bjm
s.v.12i2.149
45

To assess the
level of
TPOAb in
women in their
first trimester
of pregnancy as
well as their
general thyroid
status and to
see how they
relate to one
another in
pregnancy.

200 pregnant
women from
Bangladesh
in their first
trimester of
uncomplicated
pregnancies.

Design
Crosssectional
quantitative
study
First
trimester
serum
samples of
TSH and
TPOAb
collected.

Measurement
TPOAb level
and TSH level.
Analyzed using
SPSS Chisquare test, Z
test, and
Spearman’s
correlation
coefficient. 95%
confidence limit
(p< 0.05)

Results/
Conclusions

Positive for TPOAb
(cutoff value of >
12IU/mL) 43/200
women or 21.5%.
Mean TSH 2.12
mIU/mL +/- 1.68
mIU/mL
Women with TSH
>2.5 60/200 or 30%
R value of positive
TPOAb with
increase in TSH
level was 0.466
with a p value of
<0.01

Recommendations
Screening for TPOAb
in the first trimester of
pregnancy should be
encouraged due to the
risks involved with
TPOAb positivity.

Level/
Quality

Level II
Good
Quality
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Nazarpour,
S.,
Ramezani
Tehrani, F.,
Simbar, M.,
Tohidi, M.,
AlaviMajd,
H., & &
Azizi, F.
(2016).
Comparison
of universal
screening
with
targeted
high-risk
case finding
for diagnosis
of thyroid
disorders.
European
Journal of
Endocrinolo
gy, 174(1),
77-83. Doi:
10.1530/EJE
-15-0750

Compare the
effectiveness of
universal
screening vs.
targeted
screening in
pregnant
women for
finding thyroid
dysfunction.

1480
pregnant
Iranian
women in
their first
trimester
between
September
2013September
2014.

Crosssectional
prospective
study.

A comprehensive
questionnaire that
included a
checklist of risk
factors for
thyroid disease.

Patients
were
separated
into low and
high-risk
groups
based on lab
tests and
physical
exams.

Physical exams
including
palpation of the
thyroid, height,
weight, and blood
pressure.
TSH, FT4, &
TPOAb.

Results/
Conclusions

Normal thyroid
function 974 (65.8%).
Thyroid disorder 506
(34.2%).
445 (30.1%) had
hypothyroidism
132 (8.9%) were
positive for TPOAb
and of those 34 (2.3%
of total population)
were euthyroid.
Three most prevalent
risk factors identified
for thyroid
dysfunction included
age greater than 30
years (30.7%), family
history of thyroid
disorder (11.4%), and
history of SAB
(16.5%).
Thyroid disorders
were identified in
39.6% of high-risk
group and 27.4% of
low-risk group.

Recommendations
In this study, one third
of the women that
experienced thyroid
dysfunction were not
included in the highrisk group. It is
reasonable to screen all
women for thyroid
dysfunction in
pregnancy because of
its low cost and high
availability.

Level/
Quality

Level II
Good
Quality
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Hyperthyroidism
cases were identified
as 8 in the high-risk
group and 2 in the
low-risk group.

59
Citation

Purpose

Sample

Design

Measurement

Nor, A.M.I.,
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Kamarudin,
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M.A. (2010).
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Journal of
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Doi:
10.3109/01443
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08

To determine
the
complications
that may arise in
women who
have thyroid
disease with
positive thyroid
autoantibodies
during
pregnancy.

49
pregnant
women
with
thyroid
disease in
Malaysia.

Prospective
Observationa
l Study

TPOAb
FT4, FT3, TSH

TPOAb, FT4,
FT3, and
TSH were
taken via
serum once
during each
trimester of
pregnancy.

X2 test
difference
statistically
significant if
p<0.05

Results/
Conclusions

19 (61%) of the
women with
Grave’s Disease
and 7 (39%) of the
women with
hypothyroidism had
positive thyroid
antibodies.
Of women with
positive antibodies:
7.7% developed
hypertension,
15.4% developed
preeclampsia,
15.4% had infants
with IUGR, 3.8 %
had placental
abruption, 11.5%
had preterm
delivery, 7.7%
developed
postpartum
hemorrhage, and
19.2% had PPTD
by 8 weeks.

Recommendations
Cost may be an issue
for routine screening of
thyroid antibodies in
pregnancy, but in welldeveloped countries it
is less likely do be a
problem than in
developing countries.
In women with thyroid
antibodies, closer
monitoring is required
because of the
increased risk of
pregnancy
complication and
postpartum thyroid
dysfunction.

Level/
Quality

Level II
Fair
Quality
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Pradhan, M.,
Anand, B.,
Singh, N., &
Mehrotra, M.
(2013). Thyroid
peroxidase
antibody in
hypothyroidism:
Its effect on
pregnancy. The
Journal of
Maternal-Fetal
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Medicine, 26(6),
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To find out the
importance of
finding TPOAb
in pregnant
women and
their effect on
the outcome of
pregnancy.

2479
pregnant
women
from the
Sanjay
Gandhi
Post
Graduate
Institute
of
Medical
Sciences
antenatal
clinic in
India from
July 2009June 2011.

Prospective
Study

TSH and FT4 at
first antenatal
visit and then
those diagnosed
with
hypothyroidism
either before or
during pregnancy
had a TPOAb
level drawn as
well.

Women with
hypothyroidism
during
pregnancy
were
compared
with women
who did not
have hypothyroidism
during
pregnancy.

Results/
Conclusions

196 women (7.91%)
were found to have
hypothyroidism.
56 (40%) of those
women were TPOAb
positive.
10 (17.86%) of the
TPOAb positive
women suffered 1st
trimester SAB vs. 5
(6.49%).
6 (10.71%) of TPOAb
positive women
suffered 2nd trimester
SAB vs. 1 (1.3%).
10 (17.86%) of the
infants of TPOAb
women suffered from
malformations vs 5
(6.49%) of the TPOAb
negative women.

Recommendations
Women who have
hypothyroidism and
are TPOAb positive
should be treated
with levothyroxine
during pregnancy.
TPOAb positive
women need to be
monitored more
closely than TPOAb
negative women.
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Quinn, F.A.,
Reyes-Mendez,
M.A.,
Nicholson, L.,
Compean, L.P.,
& Tavera, M.L.
(2014).
Thyroid
function and
thyroid
autoimmunity
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pregnant and
non-pregnant
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women.
Clinical
Chemistry &
Laboratory
Medicine,
52(9), 13051311. Doi:
10.1515/cclm2014-0350

To
determine
reference
intervals
for thyroid
function
tests in
women of
Mexican
heritage.

660
pregnant
and 104
nonpregnant
Mexican
women
who were
negative
for
TPOAb
and had a
TSH
<4.94
mIU/L.

Quasiexperimental
design

TSH, FT4,
TT4, FT3, TT3,
TPOAb, and
TgAb using
ARCHITECT
analyzer.

Samples were
collected
from August
2010 to July
2011.

Tests used to
determine
differences:
Student’s t,
Mann-Whitney,
and
Kruskal_Wallis
tests.
Two tailed pvalue of
p<0.05.

Results/
Conclusions

Pregnant women with
positive TPOAb 89 or
13.5%
Non-pregnant women
with TPOAb 15 or
14.4%.
Women with positive
TPOAb had a higher
average TSH.
TSH:
Non-pregnant- 0.52-3.77
mIU/L
1st tri- 0.04-3.46 mIU/L
2nd tri- 0.6-4.22 mIU/L
3rd tri- 0.51-4.53 mIU/L
FT4:
Non-pregnant- 10.6817.63 pmol/L
1st tri- 9.65-17.89 pmol/L
2nd tri- 9.52-16.73 pmol/L
3rd tri- 8.37-14.41 pmol/L
TT4:
Non-pregnant- 4.4510.86 ug/dL
1st tri- 5.86-13.37 ug/dL
2nd tri- 7.08-14.18 ug/dL
3rd tri- 6.55-13.35 ug/dL
FT3:
Non-pregnant- 1.7-3.26
pg/mL
1st tri- 2.21-4.03 pg/mL

Recommendations
Narrower reference
intervals may need to
be used in women of
Mexican descent.
Pregnancy specific
reference intervals
should be used when
evaluating thyroid
function.
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2nd tri- 2.44-4.15 pg/mL
3rd tri- 2.14-3.61 pg/mL
TT3:
Non-pregnant: 0.63-1.68
ng/mL
1st tri- 0.82-2.05 ng/mL
2nd tri- 1.15-2.2 ng/mL
3rd tri- 1.09-1.94 ng/mL
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Sarkhail, P.,
Mehran, L.,
Tahamasbinejad,
Z., Tohidi, M., &
Azizi, F. (2016).
Maternal thyroid
function and
autoimmunity in
3 trimesters of
pregnancy and
their offspring’s
thyroid function.
Hormone and
Metabolic
Research, 48(1),
20-26. Doi:
10.1055/s003501555878

To evaluate
thyroid
dysfunction
and
autoimmunity
during
pregnancy and
how it affects
offspring.

466
pregnant
Iranian
women
during all
three
trimesters
of
pregnancy
from
November
2004 to
November
2006

Design
Quasiexperimental
study
Measurements
taken at <14
weeks, 14-27
weeks, >28
weeks, from
cord blood,
from 10 day
old newborns,
and in infants
at 2, 4, and 6
months of age.

Measurement
TT4 and TT3
measured using
RIA method,
TSH measured
using IRMA.
TPOAb and
TgAb measured
using IEMA

Results/
Conclusions

10 (8%) of the
mothers had
subclinical
hyperthyroidism
and 18 (15%) had
subclinical
hypothyroidism in
at least one
trimester.
Positive thyroid
antibodies in
women with
thyroid dysfunction
were 45.5% in 1st
trimester, 41.2% in
2nd trimester, and
25% in 3rd
trimester.
No correlation was
found between the
presence of
antibodies and
thyroid function
tests during
pregnancy.
In cord blood, 7
samples were
positive for

Recommendations
TPOAb presence in
pregnancy is closely
related to thyroid
dysfunction whereas
TgAb is not as
closely correlated
with dysfunction.
Maternal antibodies
have the most
profound effect on
the neonate in the
first trimester of
pregnancy, but more
information is needed
on the effect of TgAb
on the fetus.
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TPOAb, 6 were of
euthyroid mothers
that had TPOAb
positive results
during pregnancy.
3 samples were
positive for high
TgAb one was of
euthyroid mother,
one was of mother
with subclinical
hypothyroidism in
the first trimester
and and one was
subclinical
hypothyroidism in
the second
trimester but both
normalized in the
third trimester.
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Clinical
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42(7-8), 750753. doi:
10.1016/j.clin
biochem.2008.
12.004

To define a
reference
interval for
TSH and FT4
in the second
trimester of
pregnancy.

3102
residual
samples
from
around the
United
States of
women
14-20
weeks
gestation

Design
Quasiexperimental
study
Serum
samples
compared
between
Modular E17
Analyzer and
Elecsys
Regents for
testing thyroid
hormones.
Results were
analyzed on
Analyse it
software

Measurement
TPOAb
TgAb
TSH
FT4
Total T4
Free
triiodothryronine
And total
triiodothryronine using
ARCHITECT
i2000SR

Results/
Conclusions

14% of the samples
were positive for either
TPOAb or TgAb.
When the antibody
positive samples were
excluded, the reference
range for TSH was
0.18-4.07mIU/L
(2,660) with a 95%
confidence interval.
Reference range for
FT4 in those with
normal TSH and no
antibodies was 9.5-15.8
pmol/L (2,528).
Thyroid antibodies
may play a role in
thyroid hormone levels
during the second
trimester of pregnancy.

Recommendations
In order to
appropriately interpret
results of TSH and
FT4, the way that they
are tested needs to be
calibrated so that the
appropriate reference
ranges are being used
and further studies
must be performed
with this equipment to
determine these exact
intervals.
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To identify
normal
parameters for
TSH, fT4 and
TPO antibody
levels during
the first
trimester of
pregnancy

Sample
229
pregnant
women 912 weeks
gestation

Design
Quasi
experimental
study
TSH, FT4,
and TPOAb
using
ADVIA
Centaur
Siemens
automated
immunoassay
analyser.

Measurement
Statistical
analysis
considered to
be statistically
significant at
p<0.05 level.

Results/
Conclusions

TSH levels were
found to be slightly
higher in pregnancy.
TPO Ab levels were
found to be slightly
lower in early
pregnancy.

Recommendations
No change needs to
be made for
parameters for fT4 in
early pregnancy, but
TSH parameters
should be slightly
increased and TPOAb
should be slightly
lowered for early
pregnancy.
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E.,
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Clinical
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and
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Medicine,
50(7), 12111220. doi:
10.1515/cclm
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To take note
of the
prevalence of
thyroid
dysfunction
during
pregnancy in
asymptomatic
Czech women
and to identify
reference
ranges for
TSH, FT4 and
TPOAb during
pregnancy.

7530
pregnant
Czech
women
between
9-11
weeks
gestation.
From
20062008.

Design
Quasiexperimental
study

Measurement
Statistical
analysis found
to be significant
when p<0.05

Results/
Conclusions

Reference interval for
TSH in the first trimester
should be between 0.063.67 mU/L
Limit for TPOAb
positivity was 143 kU/L
Reference interval for FT4
was the same as a
nonpregnant adult
population of 9.8-23.0
pmol/L
1250 women had markers
out of the reference
intervals and followed up
with endocrinology. 5.1%
of them had increased
TSH, 2.9% had decreased
TSH. 11.5% were positive
for TPOAb. FT4 was
lower in TPOAb positive
women than in the general
population.
Four risk factors
identified: age greater than
30 years, family history of
thyroid dysfunction,

Recommendations
Case sensitive
screening of thyroid
dysfunction in those
women with family
history of thyroid
disease, personal
history of diabetes,
and history of having
thyroid dysfunction.
Women positive for
TPOAb should be
closely monitored.
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personal history of thyroid
dysfunction, and goiter.
Of the 11.5% of women
positive for TPOAb, 40%
of them suffered from
thyroid dysfunction greater
than 1 year postpartum.
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To assess
immunoassays
in the third
trimester of
pregnancy to
see if TPOAb
affected future
sensorineural
hearing loss
(SNHL) in the
offspring of
TPOAb
positive
women.

1859
frozen
serum
samples
stored at
-20
degrees
Celsius.
Serums
drawn
from
pregnant
women in
Baltimore,
MD
between
19591965.

Observational
cohort study.

Frozen serum samples
tested for TPOAb in
the third trimester of
pregnancy using
QUANTA Lite TPO.

Serum
samples taken
from women
during
pregnancy
were analyzed
later and then
follow-up with
the offspring
was
conducted.

Range was considered
statistically significant
if greater than or equal
to 62.5 IU/ml, and
then greater than or
equal to 31.25IU/ml to
increase sensitivity.
Audiology
examination at 8 years
of age in offspring,
which used bone and
air conduction
methods.
P >0.20
Student’s t and
Whitney-Wilcoxon
tests

Results/
Conclusions

74 (4.3%) of
children had SNHL
in primary case
definition and when
parameters were
expanded 103
(7.5%).
Of the 22 children of
mothers with
positive TPOAb at
>62.5, 5 (22.7%)
had SNHL versus
those that tested
positive at >31.25 6
(18.8%) had SNHL.
Overall incidence of
SNHL in the entire
population was 1.3%

Recommendations
Additional studies
on how TPOAb
affects children are
needed.
Screen mothers in
early pregnancy for
TPOAb and fT4 and
if positive, follow an
algorithm to
continue testing for
TPOAb even if TSH
values remain
normal.
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To determine if
using targeted
case finding is
the best way to
find women
with thyroid
disorders
during the first
and second
trimesters of
pregnancy.

Sample
3,882
Chinese
women

Design
Prospective
Cohort Study
Women were
divided into
groups of
high risk and
non-high risk
based on
history,
physical, or
any other
implications
of thyroid
dysfunction.

Measurement
Fasting TSH,
FT4, and TPO
Ab taken during
the first and
second trimester
of pregnancy.

Results/
Conclusions

TPOAb positivity was
higher in the high-risk
group than the nonhigh risk group. 118
(10.1%) of the total
population was
positive. 30 (11.7%)
of the high-risk
women vs 88 (9.6%)
of the non-high-risk
women.
Overt hypo or
hyperthyroidism was
more likely in those
placed in the high-risk
group.

Recommendations
Since it is easy to test
for and relatively
inexpensive, universal
screening for TSH,
FT4, and TPOAb is a
better option than just
screening high-risk
women.
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